The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(trans-3-(5-(5-Ethoxypyridin-2-yl)-4-(2-fluorophenyl)-4H-1,2,4-triazol-3-yl)cyclobutyl)-2,3-dimethylquinoxaline-5-carboxamide ID: ALA5093410
PubChem CID: 166636184
Max Phase: Preclinical
Molecular Formula: C30H28FN7O2
Molecular Weight: 537.60
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1ccc(-c2nnc([C@H]3C[C@H](NC(=O)c4cccc5nc(C)c(C)nc45)C3)n2-c2ccccc2F)nc1
Standard InChI: InChI=1S/C30H28FN7O2/c1-4-40-21-12-13-25(32-16-21)29-37-36-28(38(29)26-11-6-5-9-23(26)31)19-14-20(15-19)35-30(39)22-8-7-10-24-27(22)34-18(3)17(2)33-24/h5-13,16,19-20H,4,14-15H2,1-3H3,(H,35,39)/t19-,20-
Standard InChI Key: WKQVRVDAGFYXDR-MXVIHJGJSA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
4.1437 -4.4657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9692 -4.4657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2276 -3.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5564 -3.1903 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8936 -3.6807 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0098 -3.4193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7415 -3.7995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1218 -3.0678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3859 -2.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9075 -2.8122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0827 -2.0049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8685 -1.7452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4638 -1.4490 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4329 -1.2336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8117 -0.6794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0289 -0.9373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2628 -2.0432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4775 -2.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3054 -3.0984 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9136 -3.6529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7007 -3.3932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8691 -2.5894 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4504 -5.1229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6673 -5.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8578 -5.0312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3810 -5.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7083 -6.4305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5213 -6.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9986 -5.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2322 -7.0917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4236 -7.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9433 -7.6634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1135 -5.8641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5940 -6.5209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4041 -6.4352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7314 -5.6870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2530 -5.0334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5774 -4.2892 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.7479 -4.4481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3099 -3.9338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 6 1 0
6 3 1 6
8 10 1 1
10 11 1 0
11 12 1 0
11 13 2 0
12 18 2 0
17 14 2 0
14 15 1 0
15 16 2 0
16 12 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
2 23 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
1 24 1 0
27 30 1 0
30 31 1 0
31 32 1 0
23 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 23 1 0
37 38 1 0
20 39 1 0
21 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 537.60Molecular Weight (Monoisotopic): 537.2289AlogP: 5.10#Rotatable Bonds: 7Polar Surface Area: 107.71Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 1.28CX LogP: 3.43CX LogD: 3.43Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.31Np Likeness Score: -1.57
References 1. Leenders RGG, Brinch SA, Sowa ST, Amundsen-Isaksen E, Galera-Prat A, Murthy S, Aertssen S, Smits JN, Nieczypor P, Damen E, Wegert A, Nazaré M, Lehtiö L, Waaler J, Krauss S.. (2021) Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II., 64 (24.0): [PMID:34878777 ] [10.1021/acs.jmedchem.1c01264 ]